Hedwig M. A. D‘Agnolo

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease

Esther Meijer, Folkert W. Visser, R. Aerts et al. · JAMA · 2018 · 102 citations · Full text

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease

R. Aerts, Wietske Kievit, Hedwig M. A. D‘Agnolo et al. · Gastroenterology · 2019 · 82 citations · Full text

Urology, Hepatology, Medicine +9

Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease

Esther Meijer, Joost P.H. Drenth, Hedwig M. A. D‘Agnolo et al. · American Journal of Kidney Diseases · 2013 · 70 citations · Full text

Urology, Medicine, Kidney Failure +8

Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial

Hedwig M. A. D‘Agnolo, Wietske Kievit, R. Bart Takkenberg et al. · Journal of Hepatology · 2016 · 49 citations

Urology, Hepatology, Medicine +10

Impact of liver volume on polycystic liver disease-related symptoms and quality of life

Myrte K. Neijenhuis, Wietske Kievit, Stef MH Verheesen et al. · United European Gastroenterology Journal · 2017 · 45 citations · Full text